In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Atara Biotherapeutics Inc (NASDAQ: ATRA) closed the day trading at $0.66 down -4.44% from the previous closing price of $0.69. In other words, the price has decreased by -$4.44 from its previous closing price. On the day, 1.63 million shares were traded. ATRA stock price reached its highest trading level at $0.7074 during the session, while it also had its lowest trading level at $0.6401.
Ratios:
For a better understanding of ATRA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.65 and its Current Ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on November 09, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $31 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’24 when Touchon Pascal sold 24,844 shares for $0.72 per share. The transaction valued at 17,888 led to the insider holds 1,910,652 shares of the business.
Nguyen AnhCo sold 10,746 shares of ATRA for $7,737 on Mar 04 ’24. The EVP, Chief Sci. & Tech Officer now owns 941,397 shares after completing the transaction at $0.72 per share. On Mar 04 ’24, another insider, Murugan Amar, who serves as the EVP, Chief Legal Officer of the company, sold 10,044 shares for $0.72 each. As a result, the insider received 7,232 and left with 727,521 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATRA now has a Market Capitalization of 78896304 and an Enterprise Value of 87658448. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.21. Its current Enterprise Value per Revenue stands at 10.225 whereas that against EBITDA is -0.331.
Stock Price History:
Over the past 52 weeks, ATRA has reached a high of $3.06, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -9.94%, while the 200-Day Moving Average is calculated to be -40.66%.
Shares Statistics:
Over the past 3-months, ATRA traded about 2.71M shares per day on average, while over the past 10 days, ATRA traded about 1048680 shares per day. A total of 119.36M shares are outstanding, with a floating share count of 110.12M. Insiders hold about 7.74% of the company’s shares, while institutions hold 60.76% stake in the company. Shares short for ATRA as of 1711584000 were 11227598 with a Short Ratio of 4.15, compared to 1709164800 on 10144474. Therefore, it implies a Short% of Shares Outstanding of 11227598 and a Short% of Float of 9.609999499999999.
Earnings Estimates
Its stock is currently analyzed by Coterra Energy Inc. different market analysts. The consensus estimate for the next quarter is $0.66, with high estimates of $85.28 and low estimates of $139.34.
